China NMPA Drug Inspection - Hebei Qixin Traditional Chinese Medicine Granules and Slices Co., Ltd. - Bupleurum
China NMPA drug inspection for Hebei Qixin Traditional Chinese Medicine Granules and Slices Co., Ltd. published November 07, 2017. Drug: Bupleurum. The Ningxia Food and Drug Administration announced the results of its 2017 regional drug sampling inspection on November
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Hebei Qixin Traditional Chinese Medicine Granules and Slices Co., Ltd. published November 07, 2017. Drug: Bupleurum. The Ningxia Food and Drug Administration announced the results of its 2017 regional drug sampling inspection on November
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox